How to Taper Reglan (Metoclopramide)
There is no established tapering protocol for metoclopramide discontinuation—you can stop it abruptly without a gradual taper. The FDA label and current guidelines do not recommend or require a gradual dose reduction when discontinuing metoclopramide 1.
Key Points About Discontinuation
Withdrawal Symptoms
When you stop metoclopramide, patients may experience withdrawal symptoms including:
- Headaches
- Dizziness
- Nervousness
These symptoms are typically self-limited and resolve without intervention 1.
Duration Limits Are Critical
Metoclopramide should not be used for more than 12 weeks due to the risk of tardive dyskinesia (TD), which carries an FDA black box warning 2, 1. The 2025 AGA gastroparesis guidelines emphasize this 12-week maximum duration 2.
Practical Discontinuation Strategy
Drug Holidays (Alternative to Complete Discontinuation)
If ongoing treatment is needed, the 2025 AGA guidelines suggest using intermittent drug holidays rather than tapering:
- Use 1-4 week drug holidays every 8-12 weeks
- This approach aims to reduce cumulative exposure and TD risk while maintaining efficacy 2
Assessment Before Stopping
Evaluate at 4-8 weeks whether to continue or discontinue based on:
- Efficacy (symptom improvement in nausea, vomiting, early satiety)
- Adverse effects (especially movement disorders)
- If ineffective or poorly tolerated at this point, simply stop the medication 2
Important Safety Considerations
Monitor for Tardive Dyskinesia
TD can persist or even emerge after stopping metoclopramide, so watch for:
- Lip smacking, chewing, puckering
- Tongue protrusion
- Facial grimacing
- Limb movements
The actual TD risk is low (approximately 0.1% per 1000 patient-years), far below the previously estimated 1-10% 3, 4. However, there is no treatment for TD once it develops, though symptoms may lessen over time after discontinuation 1.
High-Risk Patients
Be especially vigilant when discontinuing in:
- Elderly patients (particularly women)
- Diabetics
- Those on concomitant psychotropic medications
- Patients with renal or hepatic impairment
These groups have higher risk for neurological complications 2, 3.
Bottom Line
Simply stop metoclopramide when the treatment course is complete (maximum 12 weeks) or when it's ineffective or poorly tolerated. No gradual taper is necessary. Inform patients about potential mild withdrawal symptoms (headache, dizziness) and continue monitoring for tardive dyskinesia even after discontinuation, as it can emerge or persist after stopping the drug.